DD297331A5 - Verfahren zur herstellung eines impfstoffes - Google Patents

Verfahren zur herstellung eines impfstoffes Download PDF

Info

Publication number
DD297331A5
DD297331A5 DD90343761A DD34376190A DD297331A5 DD 297331 A5 DD297331 A5 DD 297331A5 DD 90343761 A DD90343761 A DD 90343761A DD 34376190 A DD34376190 A DD 34376190A DD 297331 A5 DD297331 A5 DD 297331A5
Authority
DD
German Democratic Republic
Prior art keywords
antigen
matrix
sterol
iscom
solubilizing agent
Prior art date
Application number
DD90343761A
Other languages
German (de)
English (en)
Inventor
Neill M Mackenzie
Angela M O'sullivan
Original Assignee
Coopers Animal Health Limited,Gb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coopers Animal Health Limited,Gb filed Critical Coopers Animal Health Limited,Gb
Publication of DD297331A5 publication Critical patent/DD297331A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD90343761A 1989-09-01 1990-08-31 Verfahren zur herstellung eines impfstoffes DD297331A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898919819A GB8919819D0 (en) 1989-09-01 1989-09-01 Complexes having adjuvant activity

Publications (1)

Publication Number Publication Date
DD297331A5 true DD297331A5 (de) 1992-01-09

Family

ID=10662403

Family Applications (1)

Application Number Title Priority Date Filing Date
DD90343761A DD297331A5 (de) 1989-09-01 1990-08-31 Verfahren zur herstellung eines impfstoffes

Country Status (15)

Country Link
EP (2) EP0766967A1 (ja)
JP (1) JPH05500056A (ja)
AU (1) AU637405B2 (ja)
CA (1) CA2064911A1 (ja)
DD (1) DD297331A5 (ja)
GB (1) GB8919819D0 (ja)
HU (1) HU214110B (ja)
IE (1) IE903161A1 (ja)
LV (1) LV10394B (ja)
NZ (1) NZ235119A (ja)
PL (2) PL168316B1 (ja)
PT (1) PT95164B (ja)
WO (1) WO1991003256A1 (ja)
YU (1) YU166790A (ja)
ZA (1) ZA906977B (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE502569C2 (sv) * 1991-05-31 1995-11-13 British Tech Group Användning av en immunologiskt inert matris av en sterol och saponiner som kan bilda sfäriska nanopartiklar med snäv storleksfördelning som läkemedelsbärare, partiklar, komposition samt kit
EP0533492A3 (en) * 1991-09-18 1994-08-10 Amgen Inc A hepatitis b vaccine formulation incorporating a bile acid salt
US5338543A (en) * 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
USRE39494E1 (en) * 1992-02-27 2007-02-27 Intervet Inc. Inactivated mycoplasma hyopneumoniae and uses therefor
EP0604727A1 (en) * 1992-12-31 1994-07-06 American Cyanamid Company Improved immunogenicity of a vaccine by incorporation of a cytokine within an immune-stimulating complex containing an antigen
UA56132C2 (uk) * 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
US6464979B1 (en) * 1996-09-12 2002-10-15 Aventis Pasteur Limited Chlamydial vaccines and methods of preparation thereof
SE9801288D0 (sv) 1998-04-14 1998-04-14 Astra Ab Vaccine delivery system and metod of production
AUPP807399A0 (en) * 1999-01-08 1999-02-04 Csl Limited Improved immunogenic lhrh composition and methods relating thereto
GB0008879D0 (en) * 2000-04-12 2000-05-31 Astrazeneca Ab Polypeptide delivery system
SE0300795D0 (sv) 2003-03-24 2003-03-24 Isconova Ab Composition comprising iscom particles and live micro-organisms
GB0315323D0 (en) * 2003-07-01 2003-08-06 Royal Veterinary College Vaccine composition
US9023366B2 (en) * 2003-07-01 2015-05-05 The Royal Veterinary College Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)
TR201808733T4 (tr) 2011-10-03 2018-07-23 Mx Adjuvac Ab Kanser tedavisini ve gıda ile ilgili bileşikleri içeren tıp alanlarında amfipatik veya hidrofobik moleküller için taşıyıcı olarak nano-parçacıklar, preparasyon için proses ve bunların kullanımı.
US9907846B2 (en) 2013-04-01 2018-03-06 Mx Adjuvac Ab Nanoparticles, composed of sterol and saponin from Quillaja saponaria Molina for use in pharmaceutical compositions
CN114404583A (zh) * 2022-01-25 2022-04-29 龙岩学院 一种副猪嗜杆菌佐剂疫苗的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2039229T3 (es) * 1986-01-14 1993-09-16 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur Procedimiento para la preparacion de complejos inmunogenicos y composiciones farmaceuticas que contienen estos complejos.
NZ230747A (en) * 1988-09-30 1992-05-26 Bror Morein Immunomodulating matrix comprising a complex of at least one lipid and at least one saponin; certain glycosylated triterpenoid saponins derived from quillaja saponaria molina
AU2297888A (en) * 1988-09-30 1990-04-05 Lovgren, Karin A complex comprising adjuvants and lipids
US4981684A (en) * 1989-10-24 1991-01-01 Coopers Animal Health Limited Formation of adjuvant complexes

Also Published As

Publication number Publication date
WO1991003256A1 (en) 1991-03-21
AU6335590A (en) 1991-04-08
EP0415794A1 (en) 1991-03-06
EP0766967A1 (en) 1997-04-09
HU9200666D0 (en) 1992-05-28
NZ235119A (en) 1991-12-23
YU166790A (sh) 1994-12-28
LV10394B (en) 1995-10-20
AU637405B2 (en) 1993-05-27
HU214110B (en) 1997-12-29
JPH05500056A (ja) 1993-01-14
HUT61205A (en) 1992-12-28
PT95164B (pt) 1997-09-30
LV10394A (lv) 1995-02-20
ZA906977B (en) 1992-05-27
PL168055B1 (pl) 1995-12-30
PL168316B1 (pl) 1996-02-29
PT95164A (pt) 1991-05-22
IE903161A1 (en) 1991-03-13
PL286711A1 (en) 1991-07-15
CA2064911A1 (en) 1991-03-02
GB8919819D0 (en) 1989-10-18

Similar Documents

Publication Publication Date Title
DE69937343T2 (de) Adjuvanszusammensetzung und methoden zu deren verwendung
DE69027112T2 (de) Impfstoffzusammensetzung
DE69524624T2 (de) Saponinzubereitungen und deren verwendung in iscoms
DE60117164T2 (de) Impfstoffe mit erhöhter immunantwort und verfahren zur deren herstellung
DE69535520T2 (de) Abgeänderter, verbesserter BRSV Lebend- Impfstoff
DD297331A5 (de) Verfahren zur herstellung eines impfstoffes
DE69605296T2 (de) Impfstoffe die ein saponin und ein sterol enthalten
DE68917474T2 (de) Matrize mit immunomodulierender wirkung.
DE3712767C2 (ja)
DE69826842T2 (de) Wässerige immunologische adjuvantzusammensetzungen aus monophosphoryllipid a
DE69928763T2 (de) Adjuvanzien zur Verwendung in Impfstoffen
DE3787663T2 (de) Impfstofformulierung.
DE69623072T2 (de) Impfstoffzusammensetzung für Säugetiere enthaltend Squalen oder Squalan, Phospholipid und ein Tensid als Adjuvans
DE69232969T2 (de) Methode zur herstellung von gram-negativen bakteriellen vakzinen
DE69910253T2 (de) Verfahren zur herstellung von inaktivierten, w/ö emulsion adjuvierten, impfstoffen
DE69432665T2 (de) Multikomponentenimpfstoff aus clostridien, der saponin als adjuvans benutzt
DE3882781T2 (de) Impfstoff gegen Pasteurella.
DE3786304T2 (de) Immunostimulierende Arzneimittel.
DE2643641A1 (de) Antigene praeparate und verfahren zu ihrer herstellung
DE69131525T2 (de) Pasteurella multocida toxoid enthaltende impfstoffe
DE69031426T2 (de) Impfstoff zur immunisierung von katzen gegen toxoplasmen ohne verbreitung der oozysten
DE2538994A1 (de) Bakterieller impfstoff und verfahren zu seiner herstellung
DE69824794T2 (de) Streptococcus equi Impfstoff
DE69231724T2 (de) Fischimpfstoff gegen infektion mit aeromonas salmonicida
DE4007315A1 (de) Verwendung von zink-calciumhydroxid, lecithin und pao zur adjuvierung von antigenloesungen und auf diese weise adjuvierte antigenloesungen

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee